Overview

Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects

Status:
Completed

Trial end date:
2017-09-27

Target enrollment:

Participant gender:

Summary

The purpose of this trial is to demonstrate efficacy of desmopressin ODT against placebo for the treatment of female subjects with nocturia due to nocturnal polyuria, during 12 weeks of treatment.

Phase:

Phase 3

Details

Lead Sponsor:

Ferring Pharmaceuticals

Treatments:

Deamino Arginine Vasopressin